Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 3.119 Q1 | 233 | 62 | 196 | 12447 | 1525 | 193 | 7.67 | 200.76 | |
2 | Clinical Pharmacokinetics | journal | 1.316 Q1 | 184 | 82 | 236 | 7970 | 1235 | 228 | 4.62 | 97.20 | |
3 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
4 | AIDS Reviews | journal | 0.669 Q2 | 62 | 23 | 72 | 2160 | 126 | 72 | 2.15 | 93.91 | |
5 | Drug Resistance Updates | journal | 1.502 Q1 | 132 | 33 | 114 | 2929 | 467 | 106 | 5.09 | 88.76 | |
6 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 619 | 0 | 0 | 0.00 | 88.43 | ||
7 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
8 | Drug Metabolism Reviews | journal | 0.975 Q1 | 108 | 20 | 77 | 1644 | 267 | 75 | 3.49 | 82.20 | |
9 | Drugs | journal | 1.387 Q1 | 188 | 197 | 569 | 15384 | 2986 | 473 | 4.59 | 78.09 | |
10 | Drugs and Aging | journal | 0.794 Q1 | 109 | 90 | 221 | 6978 | 729 | 207 | 3.41 | 77.53 | |
11 | Expert Review of Neurotherapeutics | journal | 0.154 Q3 | 98 | 83 | 121 | 6239 | 40 | 113 | 0.33 | 75.17 | |
12 | CNS Drugs | journal | 1.079 Q1 | 129 | 85 | 222 | 6285 | 749 | 209 | 4.22 | 73.94 | |
13 | Paediatric Drugs | journal | 0.477 Q2 | 70 | 79 | 172 | 5792 | 327 | 169 | 1.93 | 73.32 | |
14 | Expert Opinion on Drug Safety | journal | 0.153 Q3 | 90 | 54 | 36 | 3956 | 20 | 36 | 0.56 | 73.26 | |
15 | Expert Opinion on Pharmacotherapy | journal | 0.541 Q2 | 93 | 204 | 417 | 13857 | 824 | 403 | 1.90 | 67.93 | |
16 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 154 | 3514 | 3 | 154 | 0.02 | 67.58 | |
17 | Drugs of Today | journal | 0.211 Q3 | 57 | 90 | 298 | 6018 | 178 | 296 | 0.75 | 66.87 | |
18 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | |
19 | Expert Review of Anticancer Therapy | journal | 0.354 Q2 | 85 | 90 | 201 | 5678 | 188 | 183 | 0.94 | 63.09 | |
20 | BioDrugs | journal | 0.499 Q2 | 79 | 55 | 198 | 3338 | 362 | 187 | 2.74 | 60.69 | |
21 | Pharmacien Clinicien | journal | 10 | 5 | 90 | 298 | 3 | 78 | 0.05 | 59.60 | ||
22 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.100 Q4 | 5 | 10 | 39 | 590 | 0 | 39 | 0.00 | 59.00 | |
23 | Pulmonary Pharmacology and Therapeutics | journal | 0.826 Q1 | 81 | 42 | 164 | 2456 | 356 | 158 | 2.12 | 58.48 | |
24 | American Journal of Cardiovascular Drugs | journal | 0.162 Q3 | 60 | 51 | 93 | 2980 | 31 | 81 | 0.33 | 58.43 | |
25 | Primary Care - Clinics in Office Practice | journal | 0.301 Q2 | 59 | 46 | 172 | 2641 | 147 | 159 | 0.67 | 57.41 | |
26 | Cochrane Database of Systematic Reviews | journal | 0.691 Q1 | 327 | 377 | 1683 | 21470 | 5975 | 1683 | 3.06 | 56.95 | |
27 | Topics in antiviral medicine | journal | 46 | 27 | 0 | 1457 | 0 | 0 | 0.00 | 53.96 | ||
28 | Drugs of the Future | journal | 0.435 Q2 | 46 | 93 | 256 | 4750 | 329 | 256 | 1.30 | 51.08 | |
29 | Review of Clinical Pharmacology and Pharmacokinetics, International Edition | journal | 0.187 Q3 | 9 | 12 | 123 | 611 | 15 | 123 | 0.11 | 50.92 | |
30 | Journal of Pharmacy Practice | journal | 0.107 Q4 | 38 | 47 | 146 | 2361 | 9 | 129 | 0.04 | 50.23 | |
31 | Adverse Drug Reaction Bulletin | journal | 0.247 Q3 | 8 | 6 | 17 | 291 | 9 | 17 | 0.73 | 48.50 | |
32 | Cardiovascular Drugs and Therapy | journal | 0.559 Q2 | 79 | 57 | 235 | 2692 | 302 | 196 | 1.23 | 47.23 | |
33 | Fundamental and Clinical Pharmacology | journal | 0.367 Q2 | 85 | 76 | 171 | 3587 | 207 | 166 | 1.17 | 47.20 | |
34 | Journal of Biomedical Science | journal | 0.883 Q1 | 110 | 86 | 200 | 3965 | 454 | 200 | 2.06 | 46.10 | |
35 | Chemotherapie Journal | journal | 0.184 Q3 | 15 | 22 | 90 | 972 | 53 | 81 | 0.38 | 44.18 | |
36 | Journal of Psychiatry and Neuroscience | journal | 1.172 Q1 | 114 | 46 | 142 | 2013 | 371 | 107 | 2.13 | 43.76 | |
37 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.145 Q3 | 61 | 84 | 101 | 3672 | 34 | 86 | 0.34 | 43.71 | |
38 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.636 Q2 | 57 | 45 | 120 | 1937 | 163 | 108 | 1.51 | 43.04 | |
39 | Pharmaca | journal | 0.124 Q4 | 5 | 3 | 27 | 128 | 3 | 27 | 0.14 | 42.67 | |
40 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.225 Q3 | 56 | 92 | 307 | 3899 | 192 | 307 | 0.59 | 42.38 | |
41 | Drug and Alcohol Dependence | journal | 1.439 Q1 | 187 | 155 | 391 | 6433 | 1340 | 381 | 3.07 | 41.50 | |
42 | Experimental and Clinical Psychopharmacology | journal | 0.973 Q1 | 101 | 34 | 177 | 1404 | 305 | 176 | 1.39 | 41.29 | |
43 | Japanese Journal of Neuropsychopharmacology | journal | 0.114 Q4 | 12 | 29 | 9 | 1149 | 2 | 9 | 0.22 | 39.62 | |
44 | Investigational New Drugs | journal | 0.907 Q1 | 97 | 46 | 130 | 1813 | 337 | 127 | 2.37 | 39.41 | |
45 | International Journal of Neuropsychopharmacology | journal | 1.127 Q1 | 125 | 58 | 144 | 2265 | 423 | 133 | 3.00 | 39.05 | |
46 | BMC Clinical Pharmacology | journal | 0.336 Q2 | 43 | 4 | 12 | 156 | 16 | 12 | 1.33 | 39.00 | |
47 | Trials | journal | 0.889 Q1 | 98 | 2 | 125 | 77 | 201 | 66 | 2.13 | 38.50 | |
48 | Inflammopharmacology | journal | 0.152 Q3 | 68 | 44 | 88 | 1686 | 32 | 87 | 0.37 | 38.32 | |
49 | Current Treatment Options in Oncology | journal | 0.425 Q2 | 66 | 52 | 156 | 1985 | 208 | 156 | 1.49 | 38.17 | |
50 | Psychopharmacology Bulletin | journal | 0.539 Q2 | 66 | 39 | 99 | 1485 | 140 | 99 | 1.41 | 38.08 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®